Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson's Disease - The RESISTA-PD Trial.

Genomics Proteomics Bioinformatics · 2022 · PMC9684155 · PMID 34839011

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Even though the effects on fecal calprotectin and fecal butyrate were significant in the PD + RS group and also SCFAs other than butyrate showed a trend towards an increase in concentrations in the PD + RS group, our data lack a clear-cut correlate concerning specific gut microbiota.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.